• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Blogs » The Carlat Psychiatry Blog » Pros and Cons of Using TMS for Kids

The Carlat Psychiatry Blog
The Carlat Psychiatry Blog RSS FeedRSS

Keeping psychiatry honest since 2003.
News and opinions on mental health from Dr. Carlat, the editorial team, and guest contributors.

Pros and Cons of Using TMS for Kids

August 13, 2020
There’s been some promising research for Transcranial Magnetic Stimulation (TMS), but can it be used for treatment-resistant depression in children and adolescents? Here’s a summary of the pros and cons presented in this 2019 article in The Carlat Child Psychiatry Report.

 

Pros:

It seems to work. An open-label trial of TMS for adolescents found a 44% remission rate for kids ages 13-21 years old with Treatment-Resistant Depression. The treatment period was 3 weeks, and even though it’s the largest study we have, it only covered 32 individuals. (MacMaster FP et al, Front Psychiatry 2019;10(article 170);1–6). 

It’s generally safe. A meta-analysis found side effects of TMS treatment were mild and transient. The most frequently reported side effects were headaches (11.5%), scalp discomfort (2.5%), and twitching (1.2%). Again we could use more research, this data came from 48 studies involving 513 participants within the age range of 2.5-17.8 years old. (Krishnan et al, Brain Stimulation 2015;8(1):76–87). 

Won’t affect school work.  Preliminary findings in older adolescents found that TMS doesn’t have negative effects on cognition. In fact, some evidence suggests that TMS may modestly improve verbal memory in older adolescents (Wall CA et al, Front Psychiatry 2013;4(article 165):1–8).

 

Cons:

It’s off-label. TMS is not FDA-approved for depression in children and adolescents. A standardized TMS treatment protocol has not been established yet. 

Unknown long-term effects. Studies are limited and recent. We don’t know if TMS has long-term damaging effects on the developing brain.

Not enough research. It’s challenging to provide reasonable informed consent to patients.

It's relatively expensive. Since each TMS session costs approximately $300-$500, a treatment regimen of 5 sessions per week for the first 4-6 weeks can reach a grand total anywhere from $6,000 to $15,000.

 

Bottom Line: 

Fluoxetine and CBT have the research behind them to be considered first-line treatments for depression in kids. However, when those treatments aren’t working and patients are still suffering, TMS might be a useful option. 

 

Want to learn more? Subscribers can read the full article here.
Introducing Carlat Total Access Subscriptions

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • AUDFB1e_CoilBound_Graphic2_transparent_sm.png

    (PRE-ORDER) Treating Alcohol Use Disorder—A Fact Book (2023)

    All the tools and information needed to assess and treat your patients who are struggling with...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto29377983.jpg
    Child Psychiatry

    Anxiolytics in Children and Adolescents

    Learn about the pros and cons of the main categories of medications that clinicians typically use to treat anxiety in children and adolescents.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.